Classifying dementia progression using microbial profiling of saliva

From BugSigDB
Needs review
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Bathini P, Foucras S, Dupanloup I, Imeri H, Perna A, Berruex JL, Doucey MA, Annoni JM, Auber Alberi L
Journal
Alzheimer's & dementia (Amsterdam, Netherlands)
Year
2020
Keywords:
Alzheimer's disease, cytokines, olfaction, oral microbiome
INTRODUCTION: There is increasing evidence linking periodontal infections to Alzheimer's disease (AD). Saliva sampling can reveal information about the host and pathogen interactions that can inform about physiological and pathological brain states. METHODS: A cross-sectional cohort of age-matched participants (78) was segmented according to their chemosensory (University of Pennsylvania Smell Identification Test; UPSIT) and cognitive scores (Mini-Mental State Exam; MMSE and clinical dementia rating; CDR). Mid-morning saliva was sampled from each participant and processed for microbiome composition and cytokine analysis. Linear discriminant analysis (LDA) was used to unravel specific changes in microbial and immunological signatures and logistic regression analysis (LRA) was employed to identify taxa that varied in abundance among patient groups. RESULTS: Using olfaction we distinguish in the cognitively normal population a segment with high chemosensory scores (CNh, 27) and another segment with chemosensory scores (CNr, 16) as low as mild cognitive impairment (MCI, 21) but higher than the AD group (17). We could identify stage-specific microbial signatures changes but no clearly distinct cytokine profiles. Periodontal pathogen species as Filifactor villosus decline with the increasing severity of AD, whereas opportunistic oral bacteria such as Leptotrichia wadei show a significant enrichment in MCI. CONCLUSIONS: The salivary microbiome indicates stage-dependent changes in oral bacteria favoring opportunistic species at the expense of periodontal bacteria, whereas the inflammatory profiles remain mainly unchanged in the sampled population.

Experiment 1


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Subjects

Location of subjects
Switzerland
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Alzheimer's disease [X]Dementia in Alzheimer's disease,[X]Dementia in Alzheimer's disease (disorder),AD,AD - Alzheimer's disease,Alzheimer Dementia,Alzheimer dementia,Alzheimer Dementia, Presenile,ALZHEIMER DIS,Alzheimer Disease,Alzheimer disease,Alzheimer disease, familial,Alzheimer Type Dementia,Alzheimer's,Alzheimer's Dementia,Alzheimer's dementia,Alzheimer's disease,Alzheimer's disease (disorder),Alzheimer's disease, NOS,Alzheimers,Alzheimers Dementia,Alzheimers dementia,ALZHEIMERS DIS,Alzheimers disease,DAT - Dementia Alzheimer's type,Dementia in Alzheimer's disease,Dementia in Alzheimer's disease (disorder),Dementia in Alzheimer's disease, unspecified (disorder),Dementia of the Alzheimer's type,Dementia, Alzheimer Type,Dementia, Presenile,Dementia, Presenile Alzheimer,Disease, Alzheimer,Disease, Alzheimer's,Presenile Alzheimer Dementia,sporadic Alzheimer's disease,alzheimer's disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Cognitively Normal Healthy (CNh)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Cognitively Normal at risk (CNr)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Cognitively normal people with hyposmia
Group 0 sample size Number of subjects in the control (unexposed) group
27
Group 1 sample size Number of subjects in the case (exposed) group
15

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
ANOVA
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No


Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1C

Description: Significantly different bacterial taxa in CNr and CNh

Abundance in Group 1: increased abundance in Cognitively Normal at risk (CNr)

NCBI Quality ControlLinks
Leptotrichia wadei

Revision editor(s): AaishahM

Signature 2

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 2

Description: Significantly different bacterial taxa in CNr and CNh

Abundance in Group 1: decreased abundance in Cognitively Normal at risk (CNr)

NCBI Quality ControlLinks
Filifactor villosus

Revision editor(s): AaishahM

Experiment 2


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Mild Cognitive Impairment (MCI)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Mild Cognitive Impairment (MCI)
Group 1 sample size Number of subjects in the case (exposed) group
21

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1C

Description: Significantly different bacterial taxa in MCI and CNh

Abundance in Group 1: increased abundance in Mild Cognitive Impairment (MCI)

NCBI Quality ControlLinks
Leptotrichia wadei

Revision editor(s): AaishahM

Signature 2

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1C

Description: Significantly different bacterial taxa in MCI and CNh

Abundance in Group 1: decreased abundance in Mild Cognitive Impairment (MCI)

NCBI Quality ControlLinks
Filifactor villosus

Revision editor(s): AaishahM

Experiment 3


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Alzheimer's Disease (AD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Alzheimer's Disease
Group 1 sample size Number of subjects in the case (exposed) group
17

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1C

Description: Significantly different bacterial taxa in CAD patients and CNh

Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients

NCBI Quality ControlLinks
Filifactor villosus
Leptotrichia wadei

Revision editor(s): AaishahM

Experiment 4


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Cognitively Normal at risk (CNr)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Cognitively normal people with hyposmia
Group 1 sample size Number of subjects in the case (exposed) group
15

Lab analysis

Statistical Analysis

Statistical test
Mann-Whitney (Wilcoxon)


Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1D + Figure 1E

Description: Significantly different bacterial taxa in CNr and CNh

Abundance in Group 1: decreased abundance in Cognitively Normal at risk (CNr)

NCBI Quality ControlLinks
Alloprevotella tannerae
Porphyromonas gingivalis
Filifactor alocis
Cardiobacterium valvarum

Revision editor(s): AaishahM

Experiment 5


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Mild Cognitive Impairment (MCI)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Mild Cognitive Impairment (MCI)
Group 1 sample size Number of subjects in the case (exposed) group
21

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1D + Figure 1E

Description: Significantly different bacterial taxa in MCI and CNh

Abundance in Group 1: increased abundance in Mild Cognitive Impairment (MCI)

NCBI Quality ControlLinks
Cardiobacterium valvarum

Revision editor(s): AaishahM

Signature 2

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1D + Figure 1E

Description: Significantly different bacterial taxa in MCI and CNh

Abundance in Group 1: decreased abundance in Mild Cognitive Impairment (MCI)

NCBI Quality ControlLinks
Porphyromonas gingivalis
Alloprevotella tannerae
Filifactor alocis

Revision editor(s): AaishahM

Experiment 6


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Alzheimer's Disease (AD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Alzheimer's Disease
Group 1 sample size Number of subjects in the case (exposed) group
17

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1D + Figure 1E

Description: Significantly different bacterial taxa in AD patients and CNh

Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients

NCBI Quality ControlLinks
Cardiobacterium valvarum

Revision editor(s): AaishahM

Signature 2

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure 1D + Figure 1E

Description: Significantly different bacterial taxa in AD patients and CNh

Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients

NCBI Quality ControlLinks
Porphyromonas gingivalis
Alloprevotella tannerae
Filifactor alocis

Revision editor(s): AaishahM

Experiment 7


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Cognitively Normal at risk (CNr)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Cognitively normal people with hyposmia
Group 1 sample size Number of subjects in the case (exposed) group
15

Lab analysis

Statistical Analysis

Statistical test
LEfSe
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.0


Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure S2A + Figure S2B

Description: Significantly different bacterial taxa in CNr and CNh

Abundance in Group 1: increased abundance in Cognitively Normal at risk (CNr)

NCBI Quality ControlLinks
Calothrix
Leptotrichia hofstadii
Cyanophyceae
Rothia mucilaginosa

Revision editor(s): AaishahM

Signature 2

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure S2A + Figure S2B

Description: Significantly different bacterial taxa in CNr and CNh

Abundance in Group 1: decreased abundance in Cognitively Normal at risk (CNr)

NCBI Quality ControlLinks
Peptostreptococcaceae
Filifactor
Rhodothermus
Rhodothermus clarus

Revision editor(s): AaishahM

Experiment 8


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Mild Cognitive Impairment (MCI)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Mild Cognitive Impairment (MCI)
Group 1 sample size Number of subjects in the case (exposed) group
21

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure S2C + Figure S2D

Description: Significantly different bacterial taxa in MCI and CNh

Abundance in Group 1: increased abundance in Mild Cognitive Impairment (MCI)

NCBI Quality ControlLinks
Leptotrichia
Leptotrichiaceae
Fusobacteriales
Streptococcus mutans
Streptococcus troglodytae
Leptotrichia wadei
Fusobacteriia

Revision editor(s): AaishahM

Signature 2

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure S2C + Figure S2D

Description: Significantly different bacterial taxa in MCI and CNh

Abundance in Group 1: decreased abundance in Mild Cognitive Impairment (MCI)

NCBI Quality ControlLinks
Synergistales
Synergistaceae
Spirochaetaceae
Treponema
Treponema lecithinolyticum
Dialister
Erysipelothrix
Filifactor
Spirochaetia
Spirochaetales
Alloprevotella tannerae
Prevotella intermedia
Dialister invisus
Prevotella nigrescens
Synergistia
Synergistota
Synechococcales
Bacteroides xylanisolvens
Streptococcus intermedius
Filifactor villosus
Limosilactobacillus fermentum

Revision editor(s): AaishahM

Experiment 9


Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Alzheimer's Disease (AD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Alzheimer's Disease
Group 1 sample size Number of subjects in the case (exposed) group
17

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure S2E + Figure S2F

Description: Significantly different bacterial taxa in AD patients and CNh

Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients

NCBI Quality ControlLinks
Aminiphilus
Calothrix
Kocuria
Cyanophyceae
Aminiphilus circumscriptus
Kocuria rosea
Streptococcus sobrinus

Revision editor(s): AaishahM

Signature 2

Needs review

Curated date: 2024/12/16

Curator: AaishahM

Revision editor(s): AaishahM

Source: Figure S2E + Figure S2F

Description: Significantly different bacterial taxa in AD patients and CNh

Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients

NCBI Quality ControlLinks
Spirochaetaceae
Treponema
Peptoniphilus methioninivorax
Spirochaetia
Spirochaetales
Alloprevotella tannerae
Filifactor villosus

Revision editor(s): AaishahM